Characterisation of antimony-resistant Leishmania donovani isolates: Biochemical and biophysical studies and interaction with host cells

International Journal for Parasitology

Volumn 41, Issue 13-14, 2011, Pages 1311-1321

  Mukhopadhyay, Rupkatha ^a   Mukherjee, Sandip ^a   Mukherjee, Budhaditya ^a   Naskar, Kshudiram ^a   Mondal, Dinesh ^e   Decuypere, Saskia ^d   Ostyn, Bart ^d   Prajapati, Vijay Kumar ^b   Sundar, Shyam ^b   Dujardin, Jean Claude ^c   Roy, Syamal ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b BANARAS HINDU UNIVERSITY   (India)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e INTERNATIONAL CENTRE FOR DIARRHOEAL DISEASE RESEARCH   (Bangladesh)

Author keywords

ABC transporter; Antimony resistance; Glycoconjugates; IL 10; Leishmania donovani; Membrane fluidity; Thiol metabolism

Indexed keywords

AMPHOTERICIN B; ANTIMONY; CELL PROTEIN; GLYCOPROTEIN; INTERLEUKIN 10; MILTEFOSINE; MULTIDRUG RESISTANCE PROTEIN 1; N ACETYLGALACTOSAMINYLTRANSFERASE; PAROMOMYCIN; STIBOGLUCONATE SODIUM; THIOL;

ANTIMONY; BIOCHEMISTRY; BIOPHYSICS; DRUG RESISTANCE; ENZYME; GENE EXPRESSION; MEMBRANE; METABOLISM; PARASITE; PROTEIN;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANISOTROPY; ARTICLE; BIOPHYSICS; CELL CULTURE; CELL SURVIVAL; CHEMICAL ANALYSIS; CHILD; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; EMISSION ANISOTROPY; FEMALE; HOST CELL; HOST PARASITE INTERACTION; HUMAN; IN VITRO STUDY; INDIA; LEISHMANIA DONOVANI; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE ISOLATION; PROTEIN CONTENT; PROTEIN EXPRESSION; UPREGULATION; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CRICETINAE; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; HOST-PARASITE INTERACTIONS; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, VISCERAL; MALE; MESOCRICETUS; MICE; MICE, INBRED BALB C; MIDDLE AGED; PROTOZOAN PROTEINS; YOUNG ADULT;

LEISHMANIA DONOVANI;

EID: 82355192251     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2011.07.013     Document Type: Article

References (60)

1. Adaui V., Castillo D., Zimic M., Gutierrez A., Decuypere S., Vanaerschot M., De Doncker S., Schnorbusch K., Maes I., Van der Auwera G., Maes L., Llanos-Cuentas A., Arevalo J., Dujardin J.C. Comparative gene expression analysis throughout the life cycle of Leishmania braziliensis: diversity of expression profiles among clinical isolates. PLoS Negl. Trop. Dis. 2011, 5:e1021.
2. Adaui V., Schnorbusch K., Zimic M., Gutiérrez A., Decuypere S., Vanaerschot M., De Doncker S., Maes I., Llanos-Cuentas A., Chappuis F., Arévalo J., Dujardin J.C. Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony. Parasitology 2011, 138:183-193.
3. Alexander J., Russell D.G. The interaction of Leishmania species with macrophages. Adv. Parasitol. 1992, 31:175-254.
4. Basu J.M., Mookerjee A., Sen P., Bhaumik S., Sen P., Banerjee S., Naskar K., Choudhuri S.K., Saha B., Raha S., Roy S. Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in Leishmania donovani-infected macrophages. Antimicrob. Agents Chemother. 2006, 50:1788-1797.
5. Basu J.M., Mookerjee A., Banerjee R., Saha M., Singh S., Naskar K., Tripathy G., Sinha P.K., Pandey K., Sundar S., Bimal S., Das P.K., Choudhuri S.K., Roy S. Inhibition of ABC transporters abolishes antimony resistance in Leishmania infection. Antimicrob. Agents Chemother. 2008, 52:1080-1093.
6. Bhattacharyya A., Mukherjee M., Duttagupta S. Studies on stibanate unresponsive isolates of Leishmania donovani. J. Biosci. 2002, 27:503-508.
7. Borst P., Elferink R.O. Mammalian ABC transporters in health and disease. Annu. Rev. Biochem. 2002, 71:537-592.
8. Brahmachari U.N. Note on the history of the treatment of Kala-azar with urea stibamine. J. Trop. Med. Hyg. 1922, 44:67-71.
9. Choudhury K., Zander D., Kube M., Reinhardt R., Clos J. Identification of a Leishmania infantum gene mediating resistance to miltefosine and SbIII. Int. J. Parasitol. 2008, 38:1411-1423.
10. Croft S.L., Sundar S., Fairlamb A.H. Drug resistance in Leishmaniasis. Clin. Microbiol. Rev. 2006, 19:111-126.
11. da Silva R., Sacks D.L. Metacyclogenesis is a major determinant of Leishmania promastigote virulence and attenuation. Infect. Immun. 1987, 55:2802-2806.
12. Decuypere S., Rijal S., Yardley V., De Doncker S., Laurent T., Khanal B., Chappuis F., Dujardin J.C. Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal. Antimicrob. Agents Chemother. 2005, 49:4616-4621.
13. Denny P.W., Field M.C., Smith D.F. GPI-anchored proteins and glycoconjugates segregate into lipid rafts in Kinetoplastida. FEBS Lett. 2001, 491:148-153.
14. Descoteaux A., Luo Y., Turco S.J., Beverley S.M. A specialized pathway affecting virulence glycoconjugates of Leishmania. Science 1995, 269:1869-1872.
15. Descoteaux A., Turco S.J. Glycoconjugates in Leishmania infectivity. Biochim. Biophys. Acta 1999, 1455:341-352.
16. Deumie M., Baraka M.E., Quinones E. Fluorescence quenching of pyrene derivatives by iodide compounds in erythrocyte membranes: an approach of the probe location. J. Photochem. Photobiol. A: Chem. 1995, 87:105-113.
17. Dujardin J.C. Risk factors in the spread of leishmaniases: towards integrated monitoring?. Trends Parasitol. 2006, 22:4-6.
18. Fadili E., Messier K.N., Leprohon P., Roy G., Guimond C., Trudel N., Saravia N.G., Papadopoulou B., Legare D., Ouellette M. Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes. Antimicrob. Agents Chemother. 2005, 49:1988-1993.
19. Fairlamb A.H., Blackburn P., Ulrich P., Chait B.T., Cerami A. Trypanothione: a novel bis(glutathionyl)spermidine cofactor for glutathione reductase in trypanosomatids. Science 1985, 227:1485-1487.
20. Gollapudi S., Reddy M., Gangadharam P., Tsuruo T., Gupta S. Mycobacterium tuberculosis induces expression of P-glycoprotein in promonocytic U1 cells chronically infected with HIV type 1. Biochem. Biophys. Res. Commun. 1994, 199:1181-1187.
21. Gottesman M.M., Fojo T., Bates S.E. Multidrug resistance in cancer: role of ATP dependent transporters. Nat. Rev. Cancer 2002, 2:48-58.
22. Gourbal B., Sonuc N., Bhattacharjee H., Legare D., Sundar S., Ouellette M., Rosen B., Mukhopadhyay R. Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin. J. Biol. Chem. 2004, 279:31010-31017.
23. Grondin K., Haimeur A., Mukhopadhyay R., Rosen B.P., Ouellette M. Co-amplification of the gamma-glutamylcysteine synthetase genegsh1and of the ABC transporter genepgpAin arsenite-resistantLeishmania tarentolae. EMBO J. 1997, 16:3057-3065.
24. Haimeur A., Guimond C., Pilote S., Mukhopadhyay R., Rosen B.P., Poulin R., Ouellette M. Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistantLeishmania. Mol. Microbiol. 1999, 34:726-735.
25. Haldar A.K., Yadav V., Singhal E., Bisht K.K., Singh A., Bhaumik S., Basu R., Roy S., Sen P. Leishmania donovani isolates with antimony-resistant but not-group b phenotype inhibit sodium antimony gluconate-induced dendritic cell activation. PLoS Pathog. 2010, 6:e1000907.
26. Hamelryck T.W., Loris R., Bouckaert J., Dao-Thi M., Strecker G., Imberty A., Fernandez E., Wyns L., Etzler M.E. Carbohydrate binding, quaternary structure and a novel hydrophobic binding site in two legume lectin oligomers from Dolichos biflorus. J. Mol. Biol. 1999, 286:1161-1177.
27. Huang Z.J., Haugland R.P. Partition coefficients of fluorescent probes with phospholipid membranes. Biochem. Biophys. Res. Commun. 1991, 181:166-171.
28. Ibrahim M.E., Hag Ali M., El Hassan A.M., Theander T.G., Kharazmi A. Leishmania resistant to sodium stibogluconate: drug associated macrophage killing. Parasitol. Res. 1994, 80:569-574.
29. Inocêncio da Luz R., Vermeersch M., Dujardin J.C., Cos P., Maes L. In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity formacrophage host cells. Antimicrob. Agents Chemother. 2009, 53:5197-5203.
30. Kremb S., Helfer M., Heller W., Hoffmann D., Wolff H., Kleinschmidt A., Cepok S., Hemmer B., Durner J., Brack-Werner R. EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors. Antimicrob. Agents Chemother. 2010, 54:5257-5268.
31. Lakowicz J.R. Principle of Fluorescence Spectroscopy 2006, KA/PP Publishers, New York. second ed.
32. Légaré D., Richard D., Mukhopadhyay R., Stierhof Y., Rosen B.P., Haimeur A., Papadopoulou B., Ouellette M. TheLeishmaniaATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase. J. Biol. Chem. 2001, 276:26301-26307.
33. Lentz B.R. Membrane 'fluidity' as detected by diphenyl hexatriene probes. Chem. Phys. Lipids 1989, 50:171-190.
34. Lipsitch M., Levin B.R. The population dynamics of antimicrobial chemotherapy. Antimicrob. Agents Chemother. 1997, 41:363-373.
35. Lipsitch M., Levin B.R. The within-host population dynamics of antibacterial chemotherapy: conditions for the evolution of resistance. Ciba Found. Symp. 1997, 207:122-130.
36. Luqmani Y.A. Mechanisms of drug resistance in cancer chemotherapy. Med. Princ. Pract. 2005, 14:35-48.
37. Maharjan M., Singh S., Chatterjee M., Madhubala R. Role of aquaglyceroporin (AQP1) gene and drug uptake in antimony-resistant clinical isolates of Leishmania donovani. Am. J. Trop. Med. Hyg. 2008, 79:69-75.
38. Mandal G., Wyllie S., Singh N., Sundar S., Fairlamb A.H., Chatterjee M. Increased levels of thiols protect antimony unresponsive Leishmania donovani field isolate against reactive oxygen species generated by trivalent antimony. Parasitology 2007, 134:1674-1687.
39. Marquis N., Gourbal B., Rosen B.P., Mukhopadhyay R., Ouellette M. Modulation in aquaglyceroporin AQP1 gene transcript levels in drug-resistantLeishmania. Mol. Microbiol. 2005, 57:1690-1699.
40. Mbongo N., Loiseau P.M., Billion M.A., Robert-Gero M. Mechanism of amphotericin B resistance in Leishmania donovani promastigotes. Antimicrob. Agents Chemother. 1998, 42:352-357.
41. Mukhopadhyay R., Dey S., Xut N., Gaget D., Lightbody J., Ouellette M., Rosen B.P. Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:10383-10387.
42. Mukhopadhyay S., Mandal C. Glycobiology of Leishmania donovani. Ind. J. Med. Res. 2006, 123:203-220.
43. Mukhopadhyay S., Sen P., Bhattacharyya S., Majumdar S., Roy S. Immunoprophylaxis and immunotherapy against experimental visceral leishmaniasis. Vaccine 1999, 17:291-300.
44. Murphy M.L., Wille U., Villegas E.N., Hunter C.A., Farrell J.P. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 2001, 31:2848-2856.
45. Murray H.W., Lu C.M., Mauze S., Freeman S., Moreira A.L. Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy. Infect. Immun. 2002, 70:6284-6293.
46. Nozaki T., Shigeta Y., Saito-Nakano Y., Imada M., Kruger W.D. Characterization of transsulfuration and cysteine biosynthetic pathways in the protozoan hemoflagellate, Trypanosoma cruzi. Isolation and molecular characterization of cystathionine beta-synthase and serine acetyltransferase from Trypanosoma. J. Biol. Chem. 2001, 276:6516-6523.
47. Rakotomanga M., Saint-Pierre-Chazalet M., Loiseau P.M. Alternation of fatty acid and sterol metabolism in miltefosine resistant Leishmania donovani promastigotes and consequences for drug-membrane interaction. Antimicrob. Agents Chemother. 2005, 49:2677-2686.
48. Rijal S., Yardley V., Chappuis F., Decuypere S., Khanal B., Singh R., Boelaert M., De Doncker S., Croft S., Dujardin J.C. Antimonial treatment of visceral leishmaniasis: are current in vitro susceptibility assays adequate for prognosis of in vivo therapy outcome?. Microbes Infect. 2007, 9:529-535.
49. Sarkar A., Mandal G., Singh N., Sundar S., Chatterjee M. Flow cytometric determination of intracellular non-protein thiols in Leishmania promastigotes using 5-chloromethyl fluorescein diacetate. Exp. Parasitol. 2009, 122:299-305.
50. Sharief A.H., Gasim-Khalil E.A., Theander T.G., Kharazmi A., Omer S.A., Ibrahim M.E. Leishmania donovani: an in vitro study of antimony resistant and amphotericin B-sensitive isolates. Exp. Parasitol. 2006, 114:247-252.
51. Shinitzky M., Barenholz Y. Fluidity parameters of lipid regions determined by fluorescence polarization. Biochim. Biophys. Acta 1978, 515:367-394.
52. Shinitzky M., Inbar M. Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells. J. Mol. Biol. 1974, 85:603-615.
53. Subczynski W.K., Wisniewska A. Physical properties of lipid bilayer membranes: relevance to membrane biological functions. Acta Biochim. Pol. 2000, 47:613-625.
54. t'Kindt R., Scheltema R.A., Jankevics A., Brunker K., Rijal S., Dujardin J.C., Breitling R., Watson D.G., Coombs G.H., Decuypere S. Metabolomics to unveil and understand phenotypic diversity between pathogen populations. PLoS Negl. Trop. Dis. 2010, 4:e904.
55. Thakur C.P., Mitra D.K., Narayan S. Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate. Trans. R. Soc. Trop. Med. Hyg. 2003, 97:409-412.
56. Toplak H., Batchiulis V., Hermatter A., Hunziker T., Honegger U.E., Wiesmann U.N. Effects of culture and incubation conditions on membrane fluidity in monolayer of cultured cells, measured as fluorescence anisotropy using trimethyl ammonium dimethyl hexatriene (TMA-DPH). Biochim. Biophys. Acta 1990, 1028:67-72.
57. Vanaerschot M., Maes I., Ouakad M., Adaui V., Maes L., De Doncker S., Rijal S., Chappuis F., Dujardin J.C., Decuypere S. Linking in vitro and in vivo survival of clinical Leishmania donovani strains. PLoS ONE 2010, 5(8):e12211.
58. Wyllie S., Cunningham M.L., Fairlamb A.H. Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani. J. Biol. Chem. 2004, 279:39925-39932.
59. Xing D., Dorr R., Cunningham R.P., Scholes C.P. Endonuclease III interactions with DNA substrates, 2: the DNA repair enzyme endonuclease III binds differently to intact DNA and to apyrimidinic/apurinic DNA substrates as shown by tryptophan fluorescence quenching. Biochemistry 1995, 34:2537-2544.
60. Zolese G., Gratton E., Curatola G. Phosphatidic acid affects structural organization of phosphatidylcholine liposomes. A study of 1,6-diphenyl-1,3,5-hexatriene (DPH) and 1-(4-trimethylammonium-phenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH) fluorescence decay using distributional analysis. Chem. Phys. Lipids 1990, 55:29-39.